Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression.
about
Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis.LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis.Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.Aclidinium bromide inhalation powder for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema.Phenotyping Before Starting Treatment in COPD?
P2860
Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Comparative efficacy of long-a ...... nalysis and meta-regression.
@en
type
label
Comparative efficacy of long-a ...... nalysis and meta-regression.
@en
prefLabel
Comparative efficacy of long-a ...... nalysis and meta-regression.
@en
P2860
P356
P1476
Comparative efficacy of long-a ...... nalysis and meta-regression.
@en
P2093
Nazir A Lone
P2860
P356
10.1177/1753465814565624
P577
2015-02-01T00:00:00Z